IFRX InflaRx NV

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

__________________

 

FORM 6-K

__________________

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

February, 2019

 

Commission File Number: 001-38283 

__________________________________

 

InflaRx N.V.

__________________________________

 

Winzerlaer Str. 2  

07745 Jena, Germany

(+49) 3641 508180  

(Address of principal executive offices)

__________________________________

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

 

 

INFLARX N.V.

 

On February 14, 2019 InflaRx N.V. issued a press release titled “Richard Brudnick to Join InflaRx Board of Directors.”

 

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Jena, Germany, February 14, 2019.

 

 

	INFLARX N.V.
	By:	/s/ Niels Riedemann
		Name:	Niels Riedemann
		Title:	Chief Executive Officer

 

 

EXHIBIT INDEX

 

Exhibit	Description of Exhibit
99.1	Press release dated February 14, 2019